SpaceX IPO Plans Signal Massive Investment in Rocket Technology and Artificial Intelligence Federal Reserve Rate Cut Hopes Dim as April Jobs Data Reinforces Inflation Focus Arabica Coffee Futures Surge to Record High Amid USColombia Tariff Dispute Resolution EasyJet Faces Wider FirstHalf Losses as IranConflict Fuel Costs and Softer Demand Pressure Summer Outlook Nansledan Development A New Retail Model or a Threat to Newquays High Street Loop Capital Initiates Coverage on American Express with Buy Rating Names It Top Pick Centuri Holdings Inc CTRI Q1 2026 Earnings Narrowing Loss Beats Expectations on Cost Discipline MGM Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Shares Rally Solarmax Technology Inc SMXT Q1 2026 Earnings A Challenging Start with Narrowed Losses SVCO Q1 2026 Earnings EPS Beat Signals Cost Discipline Amidst Revenue Uncertainty NOK Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines STT Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty Hyliion Holdings HYLN Surges 42 Key Levels and Market Reaction Protalix BioTherapeutics PLX Gains on Biotechnology Sector Momentum Key Levels in Focus Fortress Biotech FBIO Gains 162 as Shares Approach Key Resistance at 297 Assurant Inc AIZ Navigates Slight Decline While Holding Key Support Levels John Wiley Sons WLYB Slides 17 as Publishing Sector Faces Headwinds JPMorgans Summer Reading List for Wealthy Clients Highlights AI Leadership and Business Lessons from Lemons Anavex Life Sciences Corp AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Pipeline Progress Core Scientific Warrants CORZZ Rally 283 as Bitcoin Mining Sentiment Strengthens Kalaris Therapeutics KLRS Posts Modest Gain Holding Above Key Support Credit Suisse Asset Management Income Fund CIK Edges Lower as Resistance Holds Valhi Inc VHI Edges Higher as Support Holds Near 1200 John Hancock Premium Dividend Fund PDT Edges Higher Amid Steady Income Focus Ooma Inc OOMA Edges Higher with 132 Gain Testing Key Resistance at 2008 XChange TECINC XHG Holds Steady at 098 Consolidation or Stalemate XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level